www.fdanews.com/articles/173848-biolase-announces-update-of-waterlase-iplus-20-dental-laser
![](https://www.fdanews.com/ext/resources/test/Device_Images5/biolase.jpg?t=1447720845&width=430)
Biolase Announces Update of WaterLase iPlus 2.0 Dental Laser
November 2, 2015
Irvine, Calif.-based Biolase has announced an update of its WaterLase iPlus 2.0 dental laser to provide dentists a clinical protocol and application to assist in the management of peri-implantitis.
The condition, an inflammatory process that affects the soft and hard tissues surrounding dental implants, is a growing problem, according to Biolase President and CEO Harold C. Flynn, Jr.
The laser features the minimally invasive repair implant protocol, as well as easy access to the implant surface, a closed flap protocol that can be used for early peri-implantitis and the ability to treat site-specific or whole-mouth cases.
Biolase develops laser systems in dentistry and medicine. — Michael Cipriano